IP Attorney
+33 1 44 77 80 00 info@llrip.fr

  • Français
  • Deutsch
  • English
  • 中文 (中国)

ip excellence

Skip to content
  • LLR Group
    • About LLR
    • Timeline
    • Patent & Trademark Attorneys
    • Attorney-at-law
    • CSR
    • Why LLR?
  • Expertise
  • Team
    • Experts in Europe
    • Experts in China
    • Business associate
  • News & Documents
    • Europe and world
    • China
  • Offices
  • Unitary patent

News & Documents

Filter articles

  • Categories
  • Categories

    • Analyses
    • Events
    • News
    • Uncategorized
  • tags
  • tags

    actions en justice arbitration and mediation Biotech Brevet Brevets Brevets essentiels CCI France Chine CCP China Chine Confidentialité Conseil en propriété industrielle contracts couleur Cour d'appel Cour Suprème damages Dessins et modèles Divulgation dommages Etats-Unis France Hong Kong Intellectual Property IP/IT Law litigation lost profits lost sales Marque Marque renommée Medtech News Patent patents position Procedure Propriété intellectuelle SIPO TGI trademarks United Kingdom UPC US Supreme Court Valuation
Events

23/02/2022 – CCI France Chine : Patent Protection in China – Application of the 2020 Patent Law

CCI FRANCE CHINE's next Intellectual Property Working Group will deal with "Patent Protection in China - Application of the...

on 21 February 2022

News | Uncategorized

Best wishes for 2022!

on 04 January 2022

Events

October 20th 2021- Webinar – IP/IT in China: legal updates, recent cases, good practices

on 13 October 2021

Dispute settlement
Events

10.06 | [WEBINAR] Dispute Settlement in China-related Intellectual Property & Technology

Our speakers will explain why and how to manage dispute settlements between Chinese companies and foreign companies in IP...

on 03 June 2020

Hong Kong: new patent law
News

Hong Kong is changing its patent law

A standard patent in Hong Kong can now be filed first at the regional patent office. Is the system...

by Vincent REMY, on 26 February 2020

CCP (certificat complémentaire de protection), brevet(s), AMM, UE (ou Europe/EEE), Industrie Pharmaceutique, Innovation, médicament(s)
Analyses

SPC in Europe: bringing reduced protection ?

Quelles sont les limites et les conditions d'application des dérogations introduites par l'entrée en vigueur du règlement modifiant le...

by Myriam ALLAB, on 30 October 2019

more recent articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
older articles

Subscribe to this blog

Receive by email a notification for the publication of each new article.

  • LLR Group
    • About LLR
    • Timeline
    • Patent & Trademark Attorneys
    • Attorney-at-law
    • CSR
    • Why LLR?
  • Expertise
  • Team
    • Experts in Europe
    • Experts in China
    • Business associate
  • News & Documents
    • Europe and world
    • China
  • Offices
  • Unitary patent

Follow us

  • Blog Chine PI
  • Legal notices